Mainstream

Bioventus enters into a new $400m credit agreement, lowering interest expenses

Bioventus enters into a new $400M credit agreement, lowering interest expenses

Bioventus enters into a new $400M credit agreement, lowering interest expenses

Post ContentbvsRead More

You might also be interested in reading Morpho raises $175M at $2B valuation for institutional DeFi push.

August 4, 2025
In Mainstream